Skip to main content
Veterinary Medicines

NEOPEN, injekcinė suspensija

Authorised
  • Benzylpenicillin procaine
  • NEOMYCIN SULFATE

Product identification

Medicine name:
NEOPEN, injekcinė suspensija
Active substance:
  • Benzylpenicillin procaine
  • NEOMYCIN SULFATE
Target species:
  • Horse
  • Cattle
  • Sheep
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • NEOMYCIN SULFATE
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat
        56
        day
    • Cattle
      • Meat
        56
        day
      • Milk
        48
        hour
    • Sheep
      • Meat
        56
        day
      • Milk
        48
        hour
    • Pig
      • Meat
        45
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/95/0216/001-002
Date of authorisation status change:

Documents

RV0216.pdf

Lithuanian (PDF)
Published on: 21/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."